Success Metrics

Clinical Success Rate

100.0%

Based on 5 completed trials

Completion Rate

100%(5/5)

Active Trials

0(0%)

Results Posted

40%(2 trials)

Phase Distribution

Ph not_applicable

60%

Ph phase_3

20%

Ph phase_2

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 2Efficacy & side effects

1(20.0%)

Phase 3Large-scale testing

1(20.0%)

N/ANon-phased studies

3(60.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(5)

Detailed Status

Completed5

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 21 (20.0%)

Phase 31 (20.0%)

N/A3 (60.0%)

Trials by Status

completed5100%

Recent Activity

0 active trials

Showing 5 of 5

completednot_applicable

Vitamin D Therapy to Reduce Cardiac Damage Among Vulnerable Hypertensive Patients

NCT01360476

completedphase_2

Vitamin D Supplementation to Patients With Type 2 Diabetes

NCT00400491

Clinical Trials (5)

Showing 5 of 5 trials

NCT01229878Not Applicable

Vitamin D Supplementation in Kidney Disease

Completed

NCT00681590Phase 3

Safety of Vitamin D Supplementation in Older Persons

Completed

NCT00879424Not Applicable

Vitamin D Supplementation in Childhood Atopic Dermatitis

Completed

NCT01360476Not Applicable

Vitamin D Therapy to Reduce Cardiac Damage Among Vulnerable Hypertensive Patients

Completed

NCT00400491Phase 2

Vitamin D Supplementation to Patients With Type 2 Diabetes

Completed

All 5 trials loaded

Drug Details

Intervention Type: DIETARY SUPPLEMENT
Total Trials: 5